Published in Nucleic Acids Res on December 05, 2012
Influenza a virus assembly intermediates fuse in the cytoplasm. PLoS Pathog (2014) 1.62
At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol (2014) 1.33
A functional sequence-specific interaction between influenza A virus genomic RNA segments. Proc Natl Acad Sci U S A (2013) 1.06
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses. Proc Natl Acad Sci U S A (2013) 1.00
The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage. J Virol (2013) 0.99
Influenza A and B virus intertypic reassortment through compatible viral packaging signals. J Virol (2014) 0.97
Transport of the influenza virus genome from nucleus to nucleus. Viruses (2013) 0.91
Reassortment in segmented RNA viruses: mechanisms and outcomes. Nat Rev Microbiol (2016) 0.90
Sequential packaging of RNA genomic segments during the assembly of Bluetongue virus. Nucleic Acids Res (2014) 0.88
Disruption of Specific RNA-RNA Interactions in a Double-Stranded RNA Virus Inhibits Genome Packaging and Virus Infectivity. PLoS Pathog (2015) 0.87
Influenza virus PB1 and neuraminidase gene segments can cosegregate during vaccine reassortment driven by interactions in the PB1 coding region. J Virol (2014) 0.81
RNA structural constraints in the evolution of the influenza A virus genome NP segment. RNA Biol (2014) 0.81
Self-Folding of Naked Segment 8 Genomic RNA of Influenza A Virus. PLoS One (2016) 0.81
Positive Selection Drives Preferred Segment Combinations during Influenza Virus Reassortment. Mol Biol Evol (2015) 0.79
Generation of infectious RNA complexes in Orbiviruses: RNA-RNA interactions of genomic segments. Oncotarget (2016) 0.78
RNA Encapsidation and Packaging in the Phleboviruses. Viruses (2016) 0.78
Computational and molecular analysis of conserved influenza A virus RNA secondary structures involved in infectious virion production. RNA Biol (2016) 0.77
The Feat of Packaging Eight Unique Genome Segments. Viruses (2016) 0.77
Development and applications of single-cycle infectious influenza A virus (sciIAV). Virus Res (2015) 0.76
Complete and Incomplete Genome Packaging of Influenza A and B Viruses. MBio (2016) 0.75
Subtype-specific structural constraints in the evolution of influenza A virus hemagglutinin genes. Sci Rep (2016) 0.75
Incorporation of the influenza A virus NA segment into virions does not require cognate non-coding sequences. Sci Rep (2017) 0.75
Influenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene. Viruses (2016) 0.75
Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication. Nucleic Acid Ther (2016) 0.75
Experimental Approaches to Study Genome Packaging of Influenza A Viruses. Viruses (2016) 0.75
Protein-mediated RNA folding governs sequence-specific interactions between rotavirus genome segments. Elife (2017) 0.75
Genome-wide analysis of influenza viral RNA and nucleoprotein association. Nucleic Acids Res (2017) 0.75
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Amplification, expression, and packaging of foreign gene by influenza virus. Cell (1989) 11.21
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog (2007) 6.04
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc Natl Acad Sci U S A (1987) 4.31
The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature (2006) 3.88
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci U S A (2006) 3.25
Dimerization of human immunodeficiency virus (type 1) RNA: stimulation by cations and possible mechanism. Nucleic Acids Res (1991) 2.94
RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology (1994) 2.94
Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J (1994) 2.93
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. J Virol (2007) 2.62
Mutational analysis of influenza virus promoter elements in vivo. J Gen Virol (1995) 2.59
cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J Virol (2005) 2.50
Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45
Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA? Cell (1983) 2.42
Genome packaging in influenza A virus. J Gen Virol (2009) 2.40
Codon conservation in the influenza A virus genome defines RNA packaging signals. Nucleic Acids Res (2007) 2.24
The structure of a biologically active influenza virus ribonucleoprotein complex. PLoS Pathog (2009) 2.23
Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. J Virol (2008) 2.10
Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J (2008) 2.10
Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol (2007) 2.05
Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J Mol Biol (1992) 1.89
Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A (2010) 1.81
Mutational analyses of packaging signals in influenza virus PA, PB1, and PB2 genomic RNA segments. J Virol (2007) 1.72
Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology (1996) 1.71
A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res (2011) 1.65
Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat Commun (2012) 1.64
One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proc Natl Acad Sci U S A (2012) 1.61
Nonrandom association of parental genes in influenza A virus recombinants. Virology (1979) 1.55
Complete sequence analyses show that two defective interfering influenza viral RNAs contain a single internal deletion of a polymerase gene. Proc Natl Acad Sci U S A (1982) 1.52
Sequence relationships among defective interfering influenza viral RNAs. Proc Natl Acad Sci U S A (1979) 1.41
Origin of small RNA in von Magnus particles of influenza virus. J Virol (1979) 1.33
Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication. J Virol (2009) 1.26
The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging. J Virol (2012) 1.12
Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences. J Gen Virol (2009) 1.07
Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system. J Gen Virol (2002) 1.06
In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance? Virology (2010) 0.99
Influenza virus recombination. I. Matrix protein markers and segregation during mixed infections. Virology (1976) 0.94
Characterization of loose and tight dimer forms of avian leukosis virus RNA. J Mol Biol (2000) 0.90
Three-factor cross of influenza virus. Virology (1977) 0.89
Defective interfering influenza RNAs of polymerase 3 gene contain single as well as multiple internal deletions. Virology (1983) 0.88
Defective interfering virus associated with A/Chicken/Pennsylvania/83 influenza virus. J Virol (1987) 0.88
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis (2009) 3.76
High-resolution measurements of face-to-face contact patterns in a primary school. PLoS One (2011) 2.65
Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol (2004) 2.61
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell (2009) 2.60
Genome sequence of an Australian kangaroo, Macropus eugenii, provides insight into the evolution of mammalian reproduction and development. Genome Biol (2011) 2.18
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. Cancer Res (2010) 2.06
Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol (2010) 1.98
Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology (2008) 1.91
Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol (2009) 1.87
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol (2007) 1.86
Hierarchical architectures by synergy between dynamical template self-assembly and biomineralization. Nat Mater (2007) 1.82
Sequencing of 'untypable' enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. J Gen Virol (2003) 1.78
First snapshots of the HIV-1 RNA structure in infected cells and in virions. J Biol Chem (2004) 1.76
First-pass and steady-state MR angiography of thoracic vasculature in children and adolescents. JACC Cardiovasc Imaging (2010) 1.74
Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J (2004) 1.71
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol (2007) 1.67
RNA loop-loop interactions as dynamic functional motifs. Biochimie (2002) 1.65
The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J (2008) 1.65
A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res (2011) 1.65
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood (2009) 1.63
Structure, function and evolution of the signal recognition particle. EMBO J (2003) 1.63
In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA. J Biol Chem (2001) 1.62
Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol (2002) 1.61
Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace (2010) 1.57
Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology (2010) 1.54
Mixed respiratory virus infections. J Clin Virol (2008) 1.46
Cognitive trajectory after transcatheter aortic valve implantation. Circ Cardiovasc Interv (2013) 1.44
Apo-Hsp90 coexists in two open conformational states in solution. Biol Cell (2008) 1.39
Feasibility of outpatient coronary angiography with "ad hoc" angioplasty. Arch Cardiovasc Dis (2008) 1.38
HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms. Nucleic Acids Res (2007) 1.38
High risk HPV contamination of endocavity vaginal ultrasound probes: an underestimated route of nosocomial infection? PLoS One (2012) 1.35
Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004-2005, 2005-2006, and 2006-2007: a prospective study. Arch Intern Med (2011) 1.33
Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J (2011) 1.30
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. J Mol Biol (2004) 1.29
Evolutionary divergence of enzymatic mechanisms for posttranslational polyglycylation. Cell (2009) 1.28
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A (2005) 1.28
Epidemiology of human enterovirus 71 infections in France, 2000-2009. J Clin Virol (2010) 1.27
New enteroviruses, EV-93 and EV-94, associated with acute flaccid paralysis in the Democratic Republic of the Congo. J Med Virol (2007) 1.26
Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs). Int J Biochem Cell Biol (2004) 1.25
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med (2010) 1.24
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci (2013) 1.24
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol (2008) 1.21
Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones. Antimicrob Agents Chemother (2005) 1.16
The inner mitochondrial membrane has aquaporin-8 water channels and is highly permeable to water. J Biol Chem (2005) 1.15
Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. Emerg Infect Dis (2013) 1.14
Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol (2009) 1.13
Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA. J Mol Biol (2005) 1.13
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis (2013) 1.12
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol Mol Biol Rev (2009) 1.12
Quantitative imaging of myocardial infarct in rats with high resolution pinhole SPECT. Int J Cardiovasc Imaging (2006) 1.10
n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr (2010) 1.09
Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell. Nucleic Acids Res (2006) 1.08
Genomic anatomy of the Tyrp1 (brown) deletion complex. Proc Natl Acad Sci U S A (2006) 1.07
tmRNA-SmpB: a journey to the centre of the bacterial ribosome. EMBO J (2010) 1.06
A functional sequence-specific interaction between influenza A virus genomic RNA segments. Proc Natl Acad Sci U S A (2013) 1.06
Supramolecular organization of the yeast F1Fo-ATP synthase. Biol Cell (2008) 1.06
Influenza burden in children newborn to eleven months of age in a pediatric emergency department during the peak of an influenza epidemic. Pediatr Infect Dis J (2003) 1.06
Dual-source radiofrequency transmission with patient-adaptive local radiofrequency shimming for 3.0-T cardiac MR imaging: initial experience. Radiology (2012) 1.05
Gene expression signature-based screening identifies new broadly effective influenza a antivirals. PLoS One (2010) 1.04
Accommodation of tmRNA-SmpB into stalled ribosomes: a cryo-EM study. RNA (2009) 1.04
Advances in the structural understanding of Vif proteins. Curr HIV Res (2008) 1.03
Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli. J Virol (2002) 1.02
Association of respiratory picornaviruses with acute bronchiolitis in French infants. J Clin Virol (2006) 1.02
Visualization of cell microtubules in their native state. Biol Cell (2007) 1.02
Outbreak of acute hemorrhagic conjunctivitis in French Guiana and West Indies caused by coxsackievirus A24 variant: phylogenetic analysis reveals Asian import. J Med Virol (2005) 1.02
High-resolution myocardial stress perfusion at 3 T in patients with suspected coronary artery disease. Eur Radiol (2007) 1.01
Molecular basis of cytokine receptor activation. IUBMB Life (2010) 1.01
Structure of the mature P3-virus particle complex of cauliflower mosaic virus revealed by cryo-electron microscopy. J Mol Biol (2004) 1.01
Encephalomyelitis due to human parechovirus type 1. J Clin Virol (2002) 1.00
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses. Proc Natl Acad Sci U S A (2013) 1.00
HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation. Nucleic Acids Res (2009) 1.00
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog (2013) 1.00
Protein-induced conformational changes of RNA during the assembly of human signal recognition particle. J Mol Biol (2006) 1.00
PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest (2012) 1.00
Structural characterization of HC-Pro, a plant virus multifunctional protein. J Biol Chem (2003) 0.99
Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients. BMC Infect Dis (2012) 0.99
Comparative value of tissue Doppler imaging and m-mode color Doppler mitral flow propagation velocity for the evaluation of left ventricular filling pressure. Chest (2005) 0.99
HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A site and binds aminoglycoside antibiotics. J Biol Chem (2002) 0.98
Interaction network linking the human H3N2 influenza A virus genomic RNA segments. Vaccine (2012) 0.98
Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α. J Virol (2012) 0.98